Adcanced at-home test using your live cancer cells to match you with the most effective therapies including chemotherapy, targeted drugs, immunotherapies, and repurposed medications.
That means you might spend precious weeks or months on a therapy that doesn’t work losing valuable time and enduring side effects for nothing.
With Datar Cancer Genetics, a simple blood draw lets experts test your live cancer cells against 500+ treatment options, including 40 scientifically selected repurposed medications you won’t find in most hospital panels.
In just 14 days, you’ll know:
How to make confident, evidence-based decisions
Real-Time, Functional Testing; Not Just DNA Sequencing
Most hospital tests look at archived tumor tissue and only analyze DNA mutations. This test does more:
Testing options:
Available nationwide and in most countries. Suitable whether you’re newly diagnosed, in treatment, or exploring your next options.
When you’re facing cancer, every decision feels urgent and every week matters. The Datar Cancer Genetics test helps you avoid uncertainty and focus on treatments with the best chance of success for your cancer.
Safe. Non-invasive. No hospital referral required.
Datar Cancer Genetic uses live circulating tumor cells to measure how your cancer responds to drugs in real time not just a DNA snapshot from old tumor tissue.
A Data Genetics test evaluates how a patient’s living cancer cells respond to a broad range of treatment options, helping identify which therapies may be more or less active against that specific tumor.
The analysis includes over 500 medications, such as:
Standard chemotherapy agents
Targeted cancer therapies
Immunotherapies
Select repurposed medications, including compounds such as Fenbendazole, Ivermectin, Niclosamide, and Metformin.
Rather than relying only on genetic markers, Data Genetics uses functional testing to observe real-time cellular response, providing additional insight that may support personalized treatment discussions with a patient’s oncology team.
Independent, peer-reviewed studies have shown a high level of correlation between Data Genetics test results and real-world patient responses to certain treatments.
In multiple studies, this functional testing approach demonstrated strong predictive agreement, often exceeding 90% for specific drug responses, when comparing laboratory results with clinical outcomes.
Because results can vary by cancer type, drug class, and individual biology, the Data Genetics test is designed to be used as a decision-support tool, helping inform treatment discussions alongside clinical judgment and standard medical evaluation.
Heal Navigator acts as a facilitator and patient advocate. We help you with the ordering process and ensure your results are explained clearly by an Oncology Nurse Practitioner. Please note that Datar Cancer Genetics is the laboratory legally responsible for the testing, analysis, and medical validity of the results
Legal Disclaimer: Heal Navigator is an independent information and facilitation platform. We are not a medical facility, nor do we provide medical advice, diagnosis, or treatment. The Datar Cancer Genetics tests are performed, processed, and legally owned by Datar Cancer Genetics Ltd. Any clinical review provided by an Oncology Nurse Practitioner is for informational purposes to help you discuss options with your primary treating oncologist. Heal Navigator is not responsible for the clinical outcomes or the accuracy of the laboratory results provided by Datar Cancer Genetics.
